Chiana

Chiana
Chiana April 2025

Friday, February 14, 2025

Wellness Test Results February 2025: Stable on Dolutegravir

Chiana's Test Results Analysis

Summary

Chiana’s bloodwork results indicate mostly normal health parameters. The main point of interest is a mild elevation in SDMA, which may suggest early kidney function changes, warranting follow-up testing. Her liver function, blood sugar, and electrolyte levels are stable, while her platelet count appears low but may be due to clumping rather than a true deficiency.


1. Kidney Function

  • SDMA: 15.7 µg/dL (Mild increase, normal <15.0)
    Mildly elevated SDMA suggests potential early kidney changes; a follow-up in 2–4 weeks is recommended.
  • BUN & Creatinine: BUN at 28 mg/dL and creatinine at 1.2 mg/dL are within normal limits.

2. Liver Function

  • ALT: 28 IU/L (Normal: 10–100), and Alkaline Phosphatase: 19 IU/L (Normal: 6–102), both within normal limits.

3. Blood Sugar & Electrolytes

  • Glucose: 96 mg/dL, reflecting stable blood sugar levels.
  • Electrolytes: Sodium (150 mEq/L), Potassium (4.7 mEq/L), and Chloride (116 mEq/L) are all balanced.

4. Blood Health

  • White Blood Cells: 5.5 x 103/uL (Normal: 3.5–16.0), indicating no infection concerns.
  • Platelets: 144 x 103/uL (Reference: 200–500); low but likely due to clumping.
  • Eosinophils: Slightly elevated (10%), potentially indicating mild allergies or an immune response.

What It All Means

Chiana’s overall health is stable, with the primary focus on monitoring kidney function due to the mild SDMA elevation. A follow-up test is recommended to confirm trends.


Final Thoughts

Chiana remains in good health, with only minor concerns to monitor. Regular checkups and hydration management will help ensure her continued well-being.

Monday, February 10, 2025

Test Results: February 4, 2025: Progressive: Decrease

 

Update

In December 2024, we switched Chiana from raltegravir to dolutegravir. We also gave her a much higher dose of this drug than we had with raltegravir. For the first time ever, we have her on a dosage that's more in line with her 14 lbs. 
We did this for numerous reasons. Among them: 
1: We were able to get the drug from an overseas pharmacy at an incredibly inexpensive rate. Considering we'd been spending $1,000+ USD on raltegravir, the $300+ cost for this drug made it worth the risks.
2: The pills are smaller and easier for Chiana to digest.
3: The fact that it's given to her once a day makes it much easier for everyone to handle. 

While we'll discuss the viral load here, I'll add another post about the CBC test results (spoiler alert: no change. everything looks good).   .

We're excited to report this latest test results.

Test Results

DateStatusViral Load
12/30/24Progressive45.91 x 10⁶ = 45,910,000
2/4/25Progressive22.69 x 10⁶ = 22,690,000

Analysis

  • Chiana’s viral load dropped by 50.6% after switching from Raltegravir (RAL) to Dolutegravir (DTG).
  • This is a positive sign that Dolutegravir is working better at suppressing FeLV.
  • However, 22.69 × 10⁶ copies/mL still indicates a progressive infection, meaning the virus remains active.

Next Steps

  • Continue on 50mgs of dolutegravir / day.
  • Continue tracking any changes in her behavior or health.
  • Retesting Date: Last week of March 2025.